1. Home
  2. COMP vs AMRX Comparison

COMP vs AMRX Comparison

Compare COMP & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Inc.

COMP

Compass Inc.

HOLD

Current Price

$9.79

Market Cap

7.0B

Sector

Technology

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$20.29

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COMP
AMRX
Founded
2012
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.4B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
COMP
AMRX
Price
$9.79
$20.29
Analyst Decision
Buy
Strong Buy
Analyst Count
13
7
Target Price
$14.23
★ $22.71
AVG Volume (30 Days)
★ 14.4M
2.8M
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
67.74
★ 157.89
EPS
0.14
★ 0.37
Revenue
★ $6,961,600,000.00
N/A
Revenue This Year
$106.24
$4.53
Revenue Next Year
$7.02
$9.13
P/E Ratio
$70.93
★ $55.35
Revenue Growth
★ 23.67
N/A
52 Week Low
$6.37
$9.99
52 Week High
$13.96
$21.18

Technical Indicators

Market Signals
Indicator
COMP
AMRX
Relative Strength Index (RSI) 52.39 59.87
Support Level $9.63 $16.59
Resistance Level $13.08 $20.98
Average True Range (ATR) 0.44 0.64
MACD 0.16 -0.00
Stochastic Oscillator 72.58 83.47

Price Performance

Historical Comparison
COMP
AMRX

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: